Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.

MLA

Belshe, R. B., et al. “Neutralizing Antibodies to HIV-1 in Seronegative Volunteers Immunized with Recombinant Gp120 from the MN Strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.” JAMA, vol. 272, no. 6, Aug. 1994, pp. 475–80. EBSCOhost, https://doi.org/10.1001/jama.272.6.475.

APA

Belshe, R. B., Graham, B. S., Keefer, M. C., Gorse, G. J., Wright, P., Dolin, R., Matthews, T., Weinhold, K., Bolognesi, D. P., Sposto, R., & et. al. (1994). Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network. JAMA, 272(6), 475–480. https://doi.org/10.1001/jama.272.6.475

Chicago

Belshe, R B, B S Graham, M C Keefer, G J Gorse, P Wright, R Dolin, T Matthews, et al. 1994. “Neutralizing Antibodies to HIV-1 in Seronegative Volunteers Immunized with Recombinant Gp120 from the MN Strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.” JAMA 272 (6): 475–80. doi:10.1001/jama.272.6.475.